13F filer · CIK 1599882
Rhenman & Partners Asset Management AB
Stockholm, V7 · filing since Q4 2013 · last filing Aug 13, 2026
Reported value
$1.1B
+$248.9M vs prior
Positions
99
New / sold out
21 / 8
Added / reduced
41 / 34
Turnover
17.7%
buys $331.2M · sells $165.9M
Top-10 weight
25.1%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ASTRAZENECA PLC | +151,500 | – | +$28.5M |
| New | MERCK & CO INC | +213,500 | – | +$27.4M |
| Added | UNITED HEALTH GROUP INC | +48,100 | +105.7% | +$20.0M |
| New | JNJJOHNSON & JOHNSON | +72,500 | – | +$18.4M |
| New | CENTENE CORP DEL | +244,000 | – | +$15.7M |
| Added | DANAHER CORPORATION | +62,200 | +344.6% | +$11.8M |
| New | DEXCOM INC | +160,000 | – | +$10.8M |
| New | SPYRE THERAPEUTICS INC | +119,300 | – | +$10.6M |
| Added | ALIGN TECHNOLOGY INC | +55,500 | +740.0% | +$9.4M |
| Added | NURIX THERAPEUTICS INC | +370,750 | +118.3% | +$9.0M |
52 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | LLYLILLY ELI & CO | -11,400 | -33.8% | $-13.7M |
| Reduced | REGENERON PHARMACEUTICALS | -20,710 | -43.1% | $-12.9M |
| Reduced | VEEVA SYS INC | -68,000 | -79.7% | $-12.1M |
| Sold out | ADAPTIVE BIOTECHNOLOGIES COR | -720,000 | -100.0% | $-10.0M |
| Sold out | IQVIA HLDGS INC | -53,000 | -100.0% | $-9.0M |
| Reduced | MADRIGAL PHARMACEUTICALS INC | -16,000 | -66.5% | $-8.6M |
| Sold out | NUVALENT INC | -81,200 | -100.0% | $-8.3M |
| Reduced | OSCAR HEALTH INC | -268,000 | -40.6% | $-7.6M |
| Reduced | BOSTON SCIENTIFIC CORP | -174,500 | -27.9% | $-7.4M |
| Reduced | VERTEX PHARMACEUTICALS INC | -12,800 | -29.4% | $-6.4M |
32 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | UNITED HEALTH GROUP INCCOM | 93,600 | $38.9M | 3.67% |
| 2 | CVSCVS HEALTH CORP | 279,374 | $28.9M | 2.73% |
| 3 | ASTRAZENECA PLCORD | 151,500 | $28.5M | 2.69% |
| 4 | MERCK & CO INCCOM | 213,500 | $27.4M | 2.59% |
| 5 | LLYLILLY ELI & CO | 22,315 | $26.8M | 2.53% |
| 6 | ABBVIE INCCOM | 96,775 | $24.4M | 2.30% |
| 7 | ALIGNMENT HEALTHCARE INCCOM | 997,083 | $23.7M | 2.24% |
| 8 | EDWARDS LIFESCIENCES CORPCOM | 260,000 | $23.5M | 2.22% |
| 9 | GILEAD SCIENCES INCCOM | 178,250 | $22.5M | 2.13% |
| 10 | JAZZ PHARMACEUTICALS PLCSHS USD | 87,440 | $21.1M | 1.99% |
89 more rows. Subscribe for $29/month to see every row, download the data and use the API.